News
As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks.
Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...
Linked to neurological disorders, repeat RNAs aggregate inside droplets but can be disassembled with an engineered piece of ...
Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...
The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...
The global mRNA vaccines and therapeutics market size reached US$ 57.7 billion in 2023. Looking forward, the market is expected to reach US$ 72.7 billion by 2032, exhibiting a growth rate (CAGR ...
The new CBC-ALYREF structure revealed molecular insights into the ALYREF-mediated recruitment of mRNA export machinery to the 5' end of nascent mRNA transcripts. The structure, along with biochemical ...
The Asia Pacific region is growing at the highest CAGR in the mRNA synthesis and manufacturing market from 2024 to 2029 The mRNA synthesis and manufacturing market is segmented into six major ...
Biology diagram show concept of Central Dogma for RNA... Diagram showing the biological process of RNA splicing to remove... DNA, RNA, mRNA and Protein synthesis. Difference between... DNA, RNA, mRNA ...
Wang, Chen, and their team wanted to take on the complex challenge of designing an mRNA structure that could be stable, active, and produce sustained therapeutic effects in low doses.
Simply put, Wang’s lab wanted to design an mRNA structure that could be stable, active, and produce sustained therapeutic effects at low doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results